Ranitidine Tablets USP recall: CGMP Deviations
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
Why was Ranitidine Tablets USP recalled?
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: NBSB19001DA3, Exp. date 02/2021
- Product
- Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
- Recalling firm
- AuroMedics Pharma LLC
- Quantity
- 69696 bottles
- Distribution
- Nationwide within the United States
- Recall date
- November 6, 2019
- Classification
- Class III
- Status
- Ongoing
- Agency
- FDA (drug)